Forte Biosciences, Inc is a biotechnology business based in the US. Forte Biosciences shares (FBRX) are listed on the NASDAQ and all prices are listed in US Dollars. Forte Biosciences employs 9 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Forte Biosciences
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – FBRX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Forte Biosciences stock price (NASDAQ: FBRX)Use our graph to track the performance of FBRX stocks over time.
Forte Biosciences shares at a glance
|Latest market close||$35.54|
|52-week range||$17.90 - $53.99|
|50-day moving average||$36.32|
|200-day moving average||$34.33|
|Wall St. target price||$86.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-35.69|
Buy Forte Biosciences shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Forte Biosciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Forte Biosciences price performance over time
|1 week (2021-07-19)||N/A|
|1 month (2021-06-30)||5.71%|
|3 months (2021-04-30)||-1.80%|
|6 months (2021-01-26)||N/A|
|1 year (2020-07-26)||N/A|
|2 years (2019-07-26)||N/A|
|3 years (2018-07-26)||N/A|
|5 years (2016-07-26)||N/A|
Forte Biosciences financials
|Gross profit TTM||$0|
|Return on assets TTM||-34.06%|
|Return on equity TTM||-168.52%|
|Market capitalisation||$409.5 million|
TTM: trailing 12 months
Shorting Forte Biosciences shares
There are currently 1.3 million Forte Biosciences shares held short by investors – that's known as Forte Biosciences's "short interest". This figure is 38.6% up from 916,749 last month.
There are a few different ways that this level of interest in shorting Forte Biosciences shares can be evaluated.
Forte Biosciences's "short interest ratio" (SIR)
Forte Biosciences's "short interest ratio" (SIR) is the quantity of Forte Biosciences shares currently shorted divided by the average quantity of Forte Biosciences shares traded daily (recently around 224858.2300885). Forte Biosciences's SIR currently stands at 5.65. In other words for every 100,000 Forte Biosciences shares traded daily on the market, roughly 5650 shares are currently held short.
However Forte Biosciences's short interest can also be evaluated against the total number of Forte Biosciences shares, or, against the total number of tradable Forte Biosciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Forte Biosciences's short interest could be expressed as 0.09% of the outstanding shares (for every 100,000 Forte Biosciences shares in existence, roughly 90 shares are currently held short) or 0.1826% of the tradable shares (for every 100,000 tradable Forte Biosciences shares, roughly 183 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Forte Biosciences.
Find out more about how you can short Forte Biosciences stock.
Forte Biosciences share dividends
We're not expecting Forte Biosciences to pay a dividend over the next 12 months.
Have Forte Biosciences's shares ever split?
Forte Biosciences's shares were split on a 1:15 basis on 15 June 2020. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Forte Biosciences shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Forte Biosciences shares which in turn could have impacted Forte Biosciences's share price.
Forte Biosciences overview
Forte Biosciences Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing a live biotherapeutic FB-401 that has completed Phase 1/2a clinical trial to treat inflammatory skin diseases for pediatric atopic dermatitis patients. The company was incorporated in 2007 and is based in Torrance, California. .
Stocks similar to Forte Biosciences
Forte Biosciences in the news
Asymmetry Capital Management, L.P. Buys Centene Corp, Alkermes PLC, Kymera Therapeutics Inc, Sells Vertex Pharmaceuticals Inc, UnitedHealth Group Inc, NanoString Technologies Inc
61 Biggest Movers From Yesterday
38 Stocks Moving In Thursday's Mid-Day Session
Frequently asked questionsWhat percentage of Forte Biosciences is owned by insiders or institutions?
Currently 27.657% of Forte Biosciences shares are held by insiders and 61.809% by institutions. How many people work for Forte Biosciences?
Latest data suggests 9 work at Forte Biosciences. When does the fiscal year end for Forte Biosciences?
Forte Biosciences's fiscal year ends in December. Where is Forte Biosciences based?
Forte Biosciences's address is: 1124 West Carson Street, Torrance, CA, United States, 90502 What is Forte Biosciences's ISIN number?
Forte Biosciences's international securities identification number is: US34962G1094
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert